Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study record received a new version reflecting an update to its study status, with the latest update posted on November 4, 2026.SummaryDifference0.2%

- Check16 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check22 days agoChange DetectedA site-wide banner announces updates about NIH websites and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.3%

- Check29 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check36 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's revision tag changed from v3.6.6 to v3.7.0, indicating a new build of the site interface. This change does not modify the study record details or data.SummaryDifference0.0%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.